Package 51662-1565-1

{"route": ["INTRAVENOUS"], "spl_id": "c75311e3-ca6f-40de-e053-2a95a90a1bda", "openfda": {"unii": ["LX22YL083G", "EC2CNF7XFP"], "rxcui": ["1737723"], "spl_set_id": ["c75311e3-ca6e-40de-e053-2a95a90a1bda"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 CONTAINER (51662-1565-1)", "package_ndc": "51662-1565-1", "marketing_start_date": "20210717"}], "brand_name": "LIDOCAINE HCI AND DEXTROSE", "product_id": "51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "51662-1565", "generic_name": "LIDOCAINE HCI AND DEXTROSE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI AND DEXTROSE", "active_ingredients": [{"name": "DEXTROSE MONOHYDRATE", "strength": "5 g/100mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": ".8 g/100mL"}], "application_number": "NDA019830", "marketing_category": "NDA", "marketing_start_date": "20210717", "listing_expiration_date": "20261231"}